Sign Up for Email Alerts
Close
About Us
company
team
board
SAB
pipeline
overview
KVA12123 (VISTA)
CD27
partnerships
investors
overview
press releases
events & presentations
stock information
analyst coverage
SEC filings
corporate governance
IRS Form 8937
careers
contact
English
Korean
About Us
company
team
board
SAB
pipeline
overview
KVA12123 (VISTA)
CD27
partnerships
investors
overview
press releases
events & presentations
stock information
analyst coverage
SEC filings
corporate governance
IRS Form 8937
careers
contact
English
Korean
Kineta enters definitive agreement to be acquired by TuHURA Biosciences.
See press release for important details.
Developing
next-generation immunotherapies
Learn More
Addressing
mechanisms of
cancer immune resistance
Learn More
KVA 12123
VISTA blocking
cancer therapy
Learn More
English
English
Korean
English
English
Korean